About
Merck & Company Inc (NYSE:MRK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called "Bad" Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke
Apr 28 2026
Gastroesophageal Adenocarcinoma Market Research Report 2026, Competitive Analysis of ALX Oncology, Merck, AstraZeneca, BeOne Medicines, Taiho Pharmaceuticals, Eli Lilly - Global Forecast to 2035
Apr 27 2026
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
Apr 24 2026
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
Apr 23 2026
Survey Shows More Than 3 in 5 Americans Use AI Tools for Medical Information, but Most Take Steps to Check Sources and Information
Financials
Revenue
$65.01 B
Market Cap
$298.84 B
P/E Ratio
16.60
EPS
7.28
Dividend Yield
2.68%
Google Übersetzer